1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Thrombologic ApS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis Ilomedin and Integrilin, low molecular weight heparin. - Pneumonia | Phase 2 | Terminated | Thrombologic ApS | 5 | 2012-06-01 | 2016-04-22 |
| Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI) Ilomedin, Placebo, Ilomedin and standard low dose treatment - Myocardial Infarct | Phase 1 / Phase 2 | Completed | Thrombologic ApS | 16 | 2010-09-01 | 2011-06-02 |
Myocardial Infarction (1) · Pneumonia (1)
Eptifibatide (1) · Heparin, Low-Molecular-Weight (1) · Iloprost (1) · Therapeutics (1)
Denmark (2) · Finland (1)